Analystreport

Biohaven Ltd. (NYSE: BHVN) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $55.00 price target on the stock.

Biohaven Pharmaceutical Holding Company Ltd. Common Shares  (BHVN) 
Last biohaven pharmaceutical holding company ltd. common shares earnings: 2/25 04:45 pm Check Earnings Report
US:NYSE Investor Relations: investors.biohavenpharma.com